FDA Adverse Event Injury Summary report: N

AVAULTA SUPPORT SYSTEM

MDR report key: 1971489 · Received January 21, 2011

Report

Report Number
1018233-2011-00015
Event Type
Injury
Date Received
January 21, 2011
Report Date
December 22, 2010
Manufacturer
C.R. BARD, INC.
Product Code
FTL
PMA / PMN Number
K083839
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THE LOT NUMBER WAS NOT PROVIDED AND THEREFORE THE DEVICE HISTORY RECORD COULD NOT BE REVIEWED. THE DEVICE REMAINS IMPLANTED. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES EACH DEVICE STATES IN THE ADVERSE REACTIONS SECTION: "POTENTIAL ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING HEMATOMA, SEROMA, MUCOSAL OR VISCERAL EROSION, INFECTION, INFLAMMATION, SENSITIZATION, DYSPAREUNIA, SCARIFICATION AND CONTRACTION, FISTULA FORMATION, EXTRUSION AND RECURRENCE OF VAGINAL WALL PROLAPSE. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, RECTUM, OR ANY VISCERA MAY OCCUR DURING NEEDLE PASSAGE." THE INSTRUCTIONS FOR USE STATES UNDER PRECAUTIONS: "THE MESH SHOULD ONLY BE USED BY PHYSICIANS WHO ARE TRAINED IN THE SURGICAL PROCEDURES AND TECHNIQUES REQUIRED FOR PELVIC FLOOR RECONSTRUCTION AND THE IMPLANTATION OF NONABSORBABLE MESHES." (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED BY THE PATIENT THAT THE DEVICE THAT WAS PLACED IN 2007 BECAME ADHERED TO HER BOWEL CAUSING AN OBSTRUCTION. THE PATIENT COMPLAINS OF CHRONIC ABDOMINAL PAIN AND TAKES ORAL ANTIBIOTICS, OPIOID PAIN-RELIEVERS, AND VAGINAL DOUCHES FOR INFECTION AND BLEEDING. THE DEVICE COULD NOT BE REMOVED TO RELIEVE THE OBSTRUCTED BOWEL THEREFORE, REQUIRING PLACEMENT OF AN ENTERAL FEEDING TUBE. SEVERAL ATTEMPTS HAVE BEEN MADE TO OBTAIN ADDITIONAL INFORMATION AND HAVE BEEN UNSUCCESSFUL. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 AVAULTA SUPPORT SYSTEM FTL C.R. BARD, INC. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention